# A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)

> **NCT02284516** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 711 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Lifitegrast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02284516
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-06
- **Primary completion:** 2015-10-05
- **Final completion:** 2015-10-05
- **Target enrollment:** 711 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02284516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02284516, "A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02284516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*